Harpoon Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.83
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.56
|
-0.35
|
0.21
|
37.50%
|
|
2022-06-30
|
-0.56
|
-0.53
|
0.03
|
5.36%
|
|
2022-03-31
|
-0.55
|
-0.62
|
-0.07
|
-12.73%
|
|
2021-12-31
|
-0.42
|
-0.66
|
-0.24
|
-57.14%
|
|
2021-09-30
|
-0.52
|
-0.51
|
0.01
|
1.92%
|
|
2021-06-30
|
-0.43
|
-0.52
|
-0.09
|
-20.93%
|
|
2021-03-31
|
-0.44
|
-1.95
|
-1.51
|
-343.18%
|
|
2020-12-31
|
-0.54
|
-0.45
|
0.09
|
16.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.50
|
|
2021-12-31
|
-3.64
|
|
2020-12-31
|
-2.00
|
|
2019-12-31
|
-2.64
|
|
2018-12-31
|
-8.15
|